EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Codelivery Material System of Polymer Microfiber Structures for Synergistic Localized Therapy of Glioblastoma

Daewoo Han, Hasan Slika iD, Aanya Shahani, Eliana S Wolf, Charles G Eberhart, Henry Brem, Betty Tyler iD, Andrew J Steckl iD

ACS Biomaterials Science & Engineering · 2026

DOI: 10.1021/acsbiomaterials.5c01482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Daewoo Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nanoelectronics Laboratory, Department of Electrical and Computer Engineering, University of Cincinnati, Cincinnati, Ohio 45221, United States. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Acriflavine, Polymers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is a highly aggressive brain tumor whose treatment has improved little over the past decade. We report on the synergistic effect of the FDA-approved anti-GBM drug (temozolomide) and inhibitors (acriflavine, PT2385) of hypoxia-inducible factors (HIFs) embedded into coaxial fiber membranes (NanoMesh). In vitro cytotoxicity has been evaluated for various glioma cell lines, and synergistic drug combinations have been identified. Preliminary animal studies with the three-drug-loaded NanoMesh indicate a significant improvement of median survival of >50 days and long-term (>120 days) survival rate of 40%, indicating the potential of this material platform as a translatable local GBM therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsAcriflavinePolymersAntineoplastic AgentsDacarbazineDrug Delivery SystemsHumansAnimalsTemozolomideCell Line, TumorDrug Synergism

Stichwörter der Autor:innen

coaxial electrospinningglioblastomahypoxia inhibitorlocal drug deliverymultiple drug therapynanofibersynergism

Substanzen

TemozolomideAcriflavinePolymersAntineoplastic AgentsDacarbazine

Autor:innen und Institutionen

  • Nanoelectronics Laboratory, Department of Electrical and Computer Engineering, University of Cincinnati, Cincinnati, Ohio 45221, United States.
  • Hunterian Neurosurgical Laboratory, Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21287, United States.
  • Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland 21205, United States.
  • Departments of Oncology, Ophthalmology, and Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland 21287, United States.
  • Department of Biomedical Engineering, University of Cincinnati, Cincinnati, Ohio 45221, United States.

ORCID-Profile: Hasan Slika, Betty Tyler, Andrew J Steckl

Förderung

  • National Cancer Institute

Zitieren

APA

Han, D., Slika, H., Shahani, A., Wolf, E. S., Eberhart, C. G., Brem, H., Tyler, B., & Steckl, A. J. (2026). Codelivery Material System of Polymer Microfiber Structures for Synergistic Localized Therapy of Glioblastoma. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01482

Vancouver

Han D, Slika H, Shahani A, Wolf ES, Eberhart CG, Brem H, et al. Codelivery Material System of Polymer Microfiber Structures for Synergistic Localized Therapy of Glioblastoma. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.5c01482

BibTeX
@article{Han2026,
  author = {Han, Daewoo and Slika, Hasan and Shahani, Aanya and Wolf, Eliana S and Eberhart, Charles G and Brem, Henry and Tyler, Betty and Steckl, Andrew J},
  title = {Codelivery Material System of Polymer Microfiber Structures for Synergistic Localized Therapy of Glioblastoma},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  doi = {10.1021/acsbiomaterials.5c01482}
}
Kostenlos starten →